Glycosylation modifications have been reported in a number of disease states and, as a result, there is significant focus on the discovery and development of glycan-based biomarkers. Glyco-biomarkers have the potential to enhance the efficacy and efficiency of the diagnostic procedures for these diseases.

Keywords:
biomarker, cancer, glycosylation, rheumatoid arthritis, schizophrenia
© The Authors Journal compilation © 2011 Biochemical Society
2011
You do not currently have access to this content.